A 32-year-old male presented with swelling in the left submandibular and submental regions for 3 days, which was insidious in onset and progressive in nature.
Full article available to subscribers
A 32-year-old male presented with swelling in the left submandibular and submental regions for 3 days, which was insidious in onset and progressive in nature. Two days after the onset of swelling, he developed fever, odynophagia and a change of voice; however, there was no dyspnoea. Local inspection of the neck revealed a diffuse swelling over the left submandibular and submental regions extending across the midline, without overlying skin changes. Palpation revealed a firm-to-soft, tender swelling with local warmth. Oral and oropharyngeal examination showed no dental foci or other sources of infection except for a swelling of the left lateral pharyngeal wall and erythema of the posterior pharyngeal wall. Rigid endoscopy performed with a 70-degree scope was normal. Laboratory investigations revealed leukocytosis with a total leukocyte count of 19,000 cells/mm³. Ultrasonography of the neck revealed an organised collection in the left parapharyngeal region, from which approximately 2mL of purulent material was aspirated and sent for culture and sensitivity testing, which yielded no bacterial growth. Contrast-enhanced computed tomography (CECT) of the neck confirmed a 24×15mm peripherally enhancing hypodense collection in the left parapharyngeal space, along with thrombosis of the ipsilateral internal jugular vein (Figures 1 and 2). The patient was started on intravenous amoxicillin–potassium clavulanate 1.2g every 8 hours and metronidazole 500mg every 8 hours, and intravenous unfractionated heparin (5000IU four times daily) with a target activated partial thromboplastin time (APTT) of 1.5–2 times the baseline.
During hospitalisation, the patient showed gradual improvements in pain, swelling and fever. Follow-up ultrasonography demonstrated a resolving collection in the left parapharyngeal region. The patient was discharged on oral amoxicillin–clavulanic acid 625mg thrice daily for 2 weeks, along with an oral anticoagulant rivaroxaban 2.5mg twice daily for 3 months. He was asymptomatic at 2 months follow-up.
Patients with deep neck space infections (DNSIs) present with fever, neck pain, odynophagia, dysphagia, trismus or neck swelling, depending on the involved compartment.1 CECT is the gold-standard investigation for assessing the extent of infection, identifying abscess formation and detecting vascular complications such as internal jugular vein thrombosis (IJVT). Laboratory investigations typically demonstrate leukocytosis and raised inflammatory markers, supporting an infective aetiology. The most frequently implicated organisms in DNSI with IJVT include Fusobacterium necrophorum, Streptococcus species, Staphylococcus aureus, Bacteroides spp. and mixed anaerobic oral flora.2,3 Management requires prompt initiation of broad-spectrum intravenous antibiotics covering both aerobic and anaerobic organisms. Surgical drainage is indicated in cases with large or loculated abscesses, airway compromise or mediastinal spread.1,2
The role of anticoagulation in IJVT remains controversial. Although high-quality evidence is limited, anticoagulants are considered beneficial in preventing thrombus propagation, facilitating recanalisation and reducing the risk of embolic complications.4 The most feared complication of IJVT associated with deep neck infection is septic pulmonary embolism, which can lead to respiratory distress, sepsis and multi-organ failure if not promptly recognised and treated.3
This case highlights the need for heightened clinical vigilance in patients with progressive DNSIs, particularly those with persistent fever and increasing neck swelling, as even localised infections may rapidly progress to Lemierre’s syndrome. Hence, prompt contrast-enhanced imaging should be done to exclude IJVT and enable timely multidisciplinary management.
View Figure 1–2.
Dr Prathiba Kishore: Senior Resident, Department of ENT, All India Institute of Medical Sciences, Mangalagiri 522503, India.
Dr Satvinder Singh Bakshi, MS DNB: Professor of ENT, Dept of ENT and Head & Neck Surgery, All India Institute of Medical Sciences Mangalagiri, Guntur, Andhra Pradesh 522503, India.
Dr Soumyajit Das, MS: Additional Professor of ENT, Dept of ENT and Head & Neck Surgery, All India Institute of Medical Sciences Mangalagiri, Guntur, Andhra Pradesh 522503, India.
Dr Seepana Ramesh, MS: Additional Professor of ENT, Dept of ENT and Head & Neck Surgery, All India Institute of Medical Sciences Mangalagiri, Guntur, Andhra Pradesh 522503, India.
Dr Satvinder Singh Bakshi, MS DNB: Professor of ENT, Dept of ENT and Head & Neck Surgery, All India Institute of Medical Sciences Mangalagiri, Guntur, Andhra Pradesh 522503, India.
Nil.
1) Parhiscar A, Har-El G. Deep neck abscess: a retrospective review of 210 cases. Ann Otol Rhinol Laryngol. 2001;110(11):1051-1054. doi: 10.1177/000348940111001111.
2) Brook I. Microbiology and management of deep facial infections and Lemierre syndrome. ORL J Otorhinolaryngol Relat Spec. 2003 Mar-Apr;65(2):117-120. doi: 10.1159/000070776.
3) Riordan T. Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre's syndrome. Clin Microbiol Rev. 2007 Oct;20(4):622-659. doi: 10.1128/CMR.00011-07.
4) Adedeji A, Chukwura O, Obafemi T, et al. Anticoagulation Strategies in the Management of Lemierre Syndrome: A Systematic Review of the Literature. Ann Pharmacother. 2021 May;55(5):658-665. doi: 10.1177/1060028020957620.
Sign in to view your account and access
the latest publications by the NZMJ.
Don't have an account?
Let's get started with creating an account.
Already have an account?
Become a member to enjoy unlimited digital access and support the ongoing publication of the New Zealand Medical Journal.
The New Zealand Medical Journal is fully available to individual subscribers and does not incur a subscription fee. This applies to both New Zealand and international subscribers. Institutions are encouraged to subscribe. The value of institutional subscriptions is essential to the NZMJ, as supporting a reputable medical journal demonstrates an institution’s commitment to academic excellence and professional development. By continuing to pay for a subscription, institutions signal their support for valuable medical research and contribute to the journal's continued success.
Please email us at nzmj@pmagroup.co.nz